Madagascar has become one of the first African countries to receive[C#198601187:Merck KGaA]'s Cesol 600 (praziquantel 600mg) tablets for the treatment of schistosomiasis, under its World Health Organization (WHO) agreement to provide $80 million worth of tablets to tackle the disease.
Madagascar has become one of the first African countries to receiveMerck KGaA's Cesol 600 (praziquantel 600mg) tablets for the treatment of schistosomiasis, under its World Health Organization (WHO) agreement to provide $80 million worth of tablets to tackle the disease.
The 10-year Merck Praziquantel Donation Program, formed with the WHO in April last year,is aimed at sub-Saharan Africa, where around...
"Neque porro quisquam est qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit..."
PolyPid's D-PLEX100 meets Phase III endpoints this time around, significantly reducing surgical point infections in abdominal colorectal surgery, and is set for a US approval submission early next year.
The company will ramp up manufacturing of its Jynneos vaccine to meet demand in worst-affected African countries and stockpiling richer nations.
2030 sales forecasts for Novo’s obesity hope are an order of magnitude larger than its closest rival among 2025’s expected debutantes.
"Neque porro quisquam est qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit..."
Pipelines in bioconjugates continue to develop, from ADCs to XDCs, with radionuclide drug conjugates (RDCs) and antibody-oligonucleotide conjugates (AOCs) leading the expansion.
Interim results from the Phase III REMARK study presented at WCLC showed the Chinese company’s second-generation ALK/ROS1 inhibitor met its primary endpoint as a first-line therapy in ALK-positive advanced NSCLC.
![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
